Singapore is a recognized destination for clinical trials with multi-ethnic populations.

George Clinical In Singapore

Singapore is a recognized destination for clinical trials with multi-ethnic populations including 74% Chinese, 13% Malay and 9% Indian.

Similarly, to what George Clinical provides in Hong Kong and Taiwan, Singapore offers regulatory services which includes acting as local sponsor while managing IP importations, project management, safety and pharmacovigilance (PV) reporting services.

Key advantages of conducting clinical trials with George Clinical in Singapore include a well-established regulatory and ethics review framework; fast approval due to the Health Sciences Authority (HSA) adopting a risk-based approach in the regulations of clinical trials of therapeutic products; and paperless submissions. Commercially, clients also have the convenience of doing business in the Asian market where English is the official language.


What are the benefits of conducting clinical trials in Singapore?

    • Short start-up timeline of 3-4 months
    • Well-established RA and EC framework
    • The majority of institutions have clinical trial centers which can assist in the set-up and coordination of clinical trials
    • High-quality data and experienced GCP-trained clinical trial staff
    • Experienced key opinion leaders (KOLs) including a renal scientific leader in-country

Why is George Clinical the CRO of choice for our sponsors in Singapore?

  • We have established a presence and office with local representation
  • Experienced team with various functional heads with extensive industry experience



#32-01, 300 Beach Road, The Concourse Singapore 199555

Email: [email protected]


Population 5,638,700
Official Language English, Chinese, Malay and Tamil
Hospital Records Language English
Electronic Hospital Records All Singapore hospitals utilize a standard form of electronic medical records
In-country services Regulatory Services
Project Management
Clinical Operations
Act as Local Sponsor
Import/Export Study Supplies
GDP – per capita (US $) $72,285
Health Expenditures 3.5% of GDP

Add George Clinical to your network